Sept. 17, 2001
The United States Anti-Doping Agency (USADA) announced Monday that Tony Dees of Tampa, Fla., an athlete in the sport of track and field, tested positive at the Norwich Union Indoor Grand Prix in Birmingham, Great Britain (Feb. 18, 2001) and during an out-of-competition test in Tampa, Fla. (May 8, 2001) for nandrolone metabolites, a prohibited substance under the International Amateur Athletic Federation (IAAF) rules.
The IAAF is the international federation for the sport of track and field, and they referred both positive test results to USADA for adjudication. Nandrolone, 19-norandrosterone and 19-noretiocholanolone are all prohibited Anabolic Agents.
Dees, a member of the 1992 U.S. Olympic team, is currently serving a two-year sanction for a positive test for nandrolone metabolites at the 2001 Pontiac Grand Prix USA Indoor Track & Field Championships (March 3). The sanction for a second doping offense involving anabolic agents is lifetime ineligibility.
USA Track and Field (USATF), the national governing body for the sport in the United States, will carry out the sanction.
Dees, 37, will also be disqualified from his third-place finish in the 60-meter hurdles at the Norwich Union Indoor Grand Prix.
This is the 11th announcement issued by USADA during the past two months. USADA became the independent anti-doping agency for U.S. Olympic, Pan Am and Paralympic athletes on Oct. 2, 2000.
USADA is the independent anti-doping agency for Olympic sports in the United States, and is responsible for managing the testing and adjudication process for U.S. Olympic, Pan Am and Paralympic athletes. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.